India, March 6 -- Laurus Labs Limited has announced an investment of Rs 833 million in KRKA Pharma Private Limited (KRKA), its joint venture company. The decision was approved by the company's Board of Directors at a meeting held on March 6, 2025.
Additionally, KRKA d.d., Novo mesto, Slovenia, the co-venturer, will invest Rs 867 million, ensuring the existing 51:49 shareholding ratio between KRKA d.d. and Laurus Labs remains unchanged.
The investment will be utilized for land acquisition and initial costs to establish a manufacturing facility aimed at producing finished pharmaceutical products for new markets, including India. This move aligns with Laurus Labs' long-term strategic growth plans.
Further details, as per SEBI Master Circula...